Danske Bank’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117M Sell
299,722
-658
-0.2% -$278K 0.23% 76
2026
Q1
$142M Buy
300,380
+12,426
+4% +$6.26M 0.34% 50
2025
Q4
$134M Buy
287,954
+16,884
+6% +$7.84M 0.31% 53
2025
Q3
$116M Buy
271,070
+140,842
+108% +$54.6M 0.29% 59
2025
Q2
$49.9M Buy
130,228
+39,326
+43% +$14.2M 0.12% 144
2025
Q1
$31.4M Sell
90,902
-16,083
-15% -$5.17M 0.1% 182
2024
Q4
$32.1M Sell
106,985
-39,865
-27% -$13.9M 0.1% 186
2024
Q3
$59.7M Buy
146,850
+58,387
+66% +$21.4M 0.2% 87
2024
Q2
$28.4M Sell
88,463
-12,033
-12% -$3.91M 0.1% 171
2024
Q1
$33.5M Buy
+100,496
New +$30.7M 0.11% 177

Other funds holding HCA

Danske Bank's HCA Position: Q2 2026 in Review

Danske Bank reduced its HCA Healthcare (HCA) stake by 0.22% in Q2 2026, selling an estimated $278K and leaving 299,722 shares worth $117M. The position accounts for 0.23% of the portfolio, ranked #76.

Danske Bank first reported a position in HCA in Q1 2024 and has held it in 10 quarters since. The position peaked at $142M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Danske Bank held 299,722 shares of HCA Healthcare worth $117M as of Q2 2026.
  • Danske Bank sold 658 HCA Healthcare shares in Q2 2026, an estimated $278K.
  • HCA Healthcare made up 0.23% of Danske Bank's portfolio in Q2 2026, its #76 holding.
  • Danske Bank first reported a position in HCA Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's HCA Healthcare position peaked at $142M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.